Skip to main content
. 2022 Nov 22;24(11):e40328. doi: 10.2196/40328

Table 1.

Basic characteristics of the included studies (N=74).a

Parameter Total, n (%)
Study design

Viewpoint or comment 27 (36.5)

Quantitative 27 (36.5)

Qualitative 13 (17.6)

Mixed methods 7 (9.5)
Publication year

2007-2009 7 (9.5)

2010-2012 7 (9.5)

2013-2015 13 (17.6)

2016-2018 23 (31.1)

2019-2021 24 (32.4)
Country

Australia 3 (4.1)

Canada 1 (1.4)

New Zealand 1 (1.4)

United Kingdom 1 (1.4)

United States 68 (91.9)
Study participantsb

Children and adolescents 6454 (5.5)

Parents 110,184 (94.1)

Health care professionals 496 (0.4)

N/Ac (no participants or not specified; studies) 34 (45.9)
Treatment setting

Pediatric 34 (45.9)

Adolescent 15 (20.3)

Adult 2 (2.7)

Inpatient 15 (20.3)

Outpatient 20 (27)

Academic 1 (1.4)

N/A 7 (9.5)
Clinical field

Chronic illnesses (cystic fibrosis, juvenile idiopathic arthritis, or diabetes mellitus) 6 (8.1)

Psychiatry 4 (5.4)

Intensive care 4 (5.4)

Gastroenterology 2 (2.7)

Hematology 2 (2.7)

Obstetrics and gynecology 2 (2.7)

Neonatal care 2 (2.7)

Cancer 1 (1.4)

Cardiology 1 (1.4)

Pulmonology 1 (1.4)

Emergency 1 (1.4)

Hepatology 1 (1.4)

Subspeciality 1 (1.4)

Radiology 1 (1.4)

N/A 7 (9.5)

aIndividual papers can be assigned to various subparameters at the same time, which means that percentage totals of >100% can be achieved.

bThe number of study participants was accumulated based on empirical and observational studies that included a reported number of study participants.

cN/A: not applicable.